Coated Endotracheal Tube Market 2022 By Emerging Trends, Industry Share, Regional Overview and SWOT Analysis till 2030

Coated Endotracheal Tube Market Outlook 2031

The globalcoated endotracheal tube market was valued at US$ 159.4 Mn in 2021

The global market is projected to grow at a CAGR of 1%from 2022 to 2031

The globalcoated endotracheal tube market is anticipated to reach more than US$ 262 Mn by the end of 2031

Analysts' Viewpoint on Coated Endotracheal Tube Market Scenario

Access Full Report @ https://www.transparencymarketresearch.com/coated-endotracheal-tubes-market.html

The COVID-19 pandemic has positively impacted the global coated endotracheal tube market due to the increase in demand for endotracheal tubes for ventilation during the pandemic. Based on strict diagnostic criteria requiring microbiological confirmation, the silver-coated endotracheal tube has been linked to significant reduction in the incidence of ventilator associated pneumonia (VAP). In addition to silver, other metals such as selenium and zinc, as well as their oxides, are incorporated into or coated on polymer surfaces. Silver-coated ETTs prevent biofilm formation, thereby reducing the risk of VAP. Rise in awareness about technologically advanced endotracheal tubes and developments in nanobiotechnology and drug design are likely to propel the global market during the forecast period.

Overview of Coated Endotracheal Tube Market

Tracheal tubes play an important role in clinical medical practice. Tracheal intubation is a critical step in establishing an artificial airway and ensuring that the airway is clear, the body's oxygen demand is met, and carbon dioxide is expelled. This technique is used in endotracheal anesthesia, cardiopulmonary resuscitation, and respiratory therapy. Direct application of antimicrobial endotracheal tube is the most common antimicrobial coating method. In order to achieve the antimicrobial effect, the polymer forms a matrix on the coating surface through covalent or ionic bonding. The global coated endotracheal tube market is driven by the rise in incidence of ventilator-associated pneumonia (VAP) along with the adoption of silver-coated ETTs to reduce the incidence of VAP.

Get a sample of the report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=49899

Increase in Incidence of Ventilator-associated Pneumonia (VAP) Fueling Demand for Coated Endotracheal Tubes

The ventilator-associated pneumonia (VAP) segment accounted for the largest share of the global coated endotracheal tube market in 2021. The segment is expected to witness strong growth during the forecast period due to the increase in incidence of VAP across the world. Microaspiration of bacteria that colonize the oropharynx and upper airways in critically ill patients is the most common cause of ventilator-associated pneumonia. Nearly 86% of nosocomial pneumonias is ventilator-associated pneumonia, which is caused by mechanical ventilation. Between 250,000 and 300,000 cases are reported each year in the U.S. alone, with an incidence rate of 5 to 10 cases per 1,000 hospital admissions.

Ventilator-associated pneumonia (VAP) is one of the most common ICU-acquired infections, according to a National Library of Medicine study. Depending on the setting and diagnostic criteria, reported incidences range from 5% to 40%. VAP is linked to a longer duration of mechanical ventilation and ICU stay, with higher mortality rates in surgical ICU patients and patients with mid-range severity scores at admission. Hence, prevention of VAP using coated endotracheal tube coating is likely to drive the global market during the forecast period.

Request for Analysis of COVID-19 Impact on Coated Endotracheal Tube Market @ https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=49899

Rise in Usage of Coated Endotracheal Tubes in Mechanically Ventilated ICU Patients to Boost Market

Ventilator-associated pneumonia (VAP) is a common healthcare-associated infection (HCAI) that affects 10% to 20% of ICU patients who are mechanically ventilated. ETTs are used by nearly 120 million surgical and intensive care patients globally each year. In participants who require mechanical ventilation for 24 hours or longer, silver-coated ETT appears to show a significant reduction in the risk of VAP, particularly during the first 10 days of mechanical ventilation. Silver has broad-spectrum antibacterial activity. Patients who received a silver-coated endotracheal tube had a statistically significant reduction in the incidence of VAP and a delayed time to VAP occurrence when compared to patients who received a similar, uncoated tube. VAP increases mortality. Several measures are currently in place to prevent VAP in intensive care units (ICUs). Application of the noble metal coating on medical devices has been shown to inhibit bacterial adherence of microorganisms to the surface. Thus, rise in need of mechanical ventilation in ICU patients is expected to drive the global coated endotracheal tube market during the forecast period.

Better Isolation and Surgical Access for Intraoral Procedures Augmenting Nasotracheal Intubation Segment

In terms of intubation, the nasotracheal intubation segment held significant market share in 2021. Nasotracheal intubation (NTI) is one of the common methods for inducing anesthesia for head and neck surgeries. NTI involves passing the anesthesia endotracheal tube through the nose, allowing for better isolation and surgical access for intraoral procedures. Nasotracheal intubation is appropriate for patients who require neck immobilization for suspected cervical spine injuries, as well as those who are unable to move their necks due to cervical kyphosis, severe arthritis, or postradiation fibrosis. Furthermore, various complications associated with the tube's nasal passage, such as turbinectomy or retropharyngeal dissection, have been reported. Epistaxis is a common complication of nasotracheal intubation, which has an incidence rate of 18% to 66%.

Growth in Usage of Coated Endotracheal Tubes in Hospitals

In terms of end-user, the hospitals segment is projected to account for major share of the global coated endotracheal tube market during the forecast period. Coated endotracheal tubes are commonly used in hospital intensive care units (ICUs) to prevent hospital-acquired infections and other infections. Ventilator-associated pneumonia (VAP) is linked to longer hospital stays, higher mortality rates, and infections caused by multidrug-resistant pathogens. Therefore, preventive measures that could reduce the incidence of VAP in the ICU should be prioritized.

Make an Enquiry before Buying @ https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=49899

Regional Outlook of Global Coated Endotracheal Tube Market

North America held the largest share of around 45% of the global coated endotracheal tube market in 2021. It is projected to be a highly lucrative region of the global market during the forecast period, led by the increase in awareness about early detection of diseases and rise in number of respiratory and infectious diseases. Other factors contributing to North America's dominance are favorable reimbursement policies and high acceptance of advanced technologies. The U.S. dominates the market in North America due to the increase in incidence of hospital-acquired infections (HAIs) in the country. According to the Centers for Disease Control and Prevention (CDC), HAIs are estimated to cause 1.7 million infections and 99,000 deaths in hospitals in the U.S. each year.

The market in Europe is expected to grow rapidly, as market leaders are increasingly collaborating with research institutions and labs to develop new and innovative products. Rise in disposable income, unmet needs of the growing population, rapidly evolving healthcare network, improved reimbursement facilities, and increase in health care awareness are likely to augment the market in Europe.

Analysis of Key Players in Global Coated Endotracheal Tube Market

The global coated endotracheal tube market is consolidated with the presence of small number of leading players. Most of the companies are investing significantly in research & development of coated endotracheal tube products. Expansion of product portfolio and mergers & acquisitions are the key strategies adopted by prominent players in the global coated endotracheal tube market. BD (C. R. Bard), Venner Medical, Sterimed Group, Bactiguard AB, N8 Medical, LLC., Desco Medical India, and Fuji Systems are the key players operating in the global coated endotracheal tube market.

Request a custom report on Coated Endotracheal Tube Market

Key Developments in Global Coated Endotracheal Tube Market

On April 2, 2020, Health Canada approved the use of N8 Medical's Cerasheild endotracheal tubes in COVID-19 patients, who were mechanically ventilated. The company has patented an anti-fouling coating, which is designed to prevent deadly bacterial infections that frequently occur in ventilated patients with respiratory viral infections.

In January 2017, Bactiguard announced the launch of the new BIP endotracheal tube, Evac, for the prevention of ventilator-associated pneumonia (VAP). VAP is one of the common nosocomial infections in intensive care units.

Each of these players has been profiled in the coated endotracheal tube market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

More Related Reports by Transparency Market Research -

ECG Devices Market: https://www.transparencymarketresearch.com/ecg-devices-market.html

Cataract Surgery Devices Market: https://www.transparencymarketresearch.com/cataract-surgery-devices-market.html

RNA Sequencing Market: https://www.transparencymarketresearch.com/rna-sequencing-market.html

Dental Aligner Market: https://www.transparencymarketresearch.com/dental-aligner-market.html

Blood Pressure Monitoring Devices Market: https://www.transparencymarketresearch.com/blood-pressure-monitoring-devices-market.html

Wellness Tourism Market: https://www.transparencymarketresearch.com/wellness-tourism-market.html

Incontinence Products Market: https://www.transparencymarketresearch.com/incontinence-market.html

Contact Us
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/

About Us
Transparency Market Research is a global market intelligence company providing market research reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

This release was published on openPR.